Effects of Exergaming Session Frequency on Work Performance, Cognition, and Mobility in Adults Age 55 to 65
NCT ID: NCT03743363
Last Updated: 2020-04-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
3 participants
INTERVENTIONAL
2018-11-15
2019-02-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of Computer-Based Cognitive Game Training for Healthy Elderly
NCT03940079
Effects of the Fully Immersive Leisure-based Virtual Reality Cognitive Training for Community-dwelling Elderly
NCT05227495
Online Group-based Dual-task Training to Improve Cognitive Function of Community-dwelling Older Adults
NCT05573646
Exergaming Revolution in Dementia
NCT06631742
Effects of an Exergame Focused on Cognitive-motor Interference on the Cognitive and Motor Capacities of Older Adults
NCT04803799
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Exergame 3/week
The group does active training for 8 weeks after not training.
Exergaming 3/week
virtual training 3 times a week(8 week-long)
Exergame 2/week
The group does active training for 8 weeks after not training.
Exergame 2/week
virtual training 2 times a week(8 week-long)
Healthy control / Exergame 1/week
In the first 8 week-long only control group, The group will do 1 training/week for the next 8 weeks.
Healthy control / Exergaming 1/week
In the first 8 week-long only control group. For the next 8 weeks, the control group will do 1 workout per week.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Exergame 2/week
virtual training 2 times a week(8 week-long)
Exergaming 3/week
virtual training 3 times a week(8 week-long)
Healthy control / Exergaming 1/week
In the first 8 week-long only control group. For the next 8 weeks, the control group will do 1 workout per week.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* active worker
* no detected neurological status
Exclusion Criteria
* Sever demeanor
* Alkoholism
* Drug problems
55 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Somogy Megyei Kaposi Mór Teaching Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tollár József
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Somogy Megyei Kaposi Mór Oktató Kórház
Kaposvár, Somogy County, Hungary
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Hortobagyi T, Deak D, Farkas D, Blenyesi E, Torok K, Granacher U, Tollar J. Effects of Exercise Dose and Detraining Duration on Mobility at Late Midlife: A Randomized Clinical Trial. Gerontology. 2021;67(4):403-414. doi: 10.1159/000513505. Epub 2021 Mar 3.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IKEB009/2018
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.